Back to User profile » Dr Po-Chin Liang

Papers published by Dr Po-Chin Liang:


Original Research

Comparison of Long-Term Outcomes Between Repeated Hepatic Resection and Radiofrequency Ablation in Patients with Small Recurrent Hepatocellular Carcinoma After Initial Curative Resection: A Propensity Score Matched Study

Graphical Abstract of Comparison of Long-Term Outcomes Between Repeated Hepatic Resection and Radiofrequency Ablation in Patients with Small Recurrent Hepatocellular Carcinoma After Initial Curative Resection: A Propensity Score Matched Study

Hsiao CY, Hu RH, Liang PC, Wu CH

Journal of Hepatocellular Carcinoma 2025, 12:1587-1598

Published Date: 23 July 2025

Original Research

Comparison of Computed Tomography and Ultrasound-Guided Radiofrequency Ablation for Recurrent Subdiaphragmatic Hepatocellular Carcinoma After Resection

Liu HY, Hsiao CY, Hu RH, Liang PC, Wu CH

Journal of Hepatocellular Carcinoma 2025, 12:1231-1240

Published Date: 27 June 2025

Original Research

In Situ Vaccination with Poly-ICLC Combined with Systemic Nivolumab for the Treatment of Unresectable Hepatocellular Carcinoma

Liang JD, Liang PC, Shun CT, Chen CH, Wu YM, Hsu YC, Lee YT, Yang PM, Huang GT, Salazar AM, Lee HS, Sheu JC, Weng MT

Journal of Hepatocellular Carcinoma 2025, 12:1191-1204

Published Date: 14 June 2025

Original Research

Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma

Graphical Abstract of Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma

Chen BB, Liang PC, Shih TTF, Liu TH, Shen YC, Lu LC, Lin ZZ, Hsu C, Hsu CH, Cheng AL, Shao YY

Journal of Hepatocellular Carcinoma 2024, 11:1015-1029

Published Date: 5 June 2024

Original Research

Safety and Efficacy of Drug-Eluting Beads Trans-Arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T)

Liu YS, Chang PY, Liang PC, Ou MC, Hwang JI, Chen CH

Journal of Hepatocellular Carcinoma 2022, 9:811-821

Published Date: 15 August 2022

Clinical Trial Report

Phase I Trial on Arterial Embolization with Hypoxia Activated Tirapazamine for Unresectable Hepatocellular Carcinoma

Youtube play button
Youtube thumbnail

Abi-Jaoudeh N, Dayyani F, Chen PJ, Fernando D, Fidelman N, Javan H, Liang PC, Hwang JI, Imagawa DK

Journal of Hepatocellular Carcinoma 2021, 8:421-434

Published Date: 17 May 2021

Original Research

Doxorubicin-modified magnetic nanoparticles as a drug delivery system for magnetic resonance imaging-monitoring magnet-enhancing tumor chemotherapy

Liang PC, Chen YC, Chiang CF, Mo LR, Wei SY, Hsieh WY, Lin WL

International Journal of Nanomedicine 2016, 11:2021-2037

Published Date: 12 May 2016